These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29648575)

  • 1. Early evolutionary divergence between papillary and anaplastic thyroid cancers.
    Capdevila J; Mayor R; Mancuso FM; Iglesias C; Caratù G; Matos I; Zafón C; Hernando J; Petit A; Nuciforo P; Cameselle-Teijeiro JM; Álvarez C; Recio JA; Tabernero J; Matias-Guiu X; Vivancos A; Seoane J
    Ann Oncol; 2018 Jun; 29(6):1454-1460. PubMed ID: 29648575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.
    Teng L; Deng W; Lu J; Zhang J; Ren X; Duan H; Chuai S; Duan F; Gao W; Lu T; Wu H; Liang Z
    Oncotarget; 2017 Mar; 8(13):22023-22033. PubMed ID: 28423545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
    Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
    Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
    Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
    Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing.
    Duan H; Li Y; Hu P; Gao J; Ying J; Xu W; Zhao D; Wang Z; Ye J; Lizaso A; He Y; Wu H; Liang Z
    Histopathology; 2019 Dec; 75(6):890-899. PubMed ID: 31230400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological features of BRAF V600E-mutant anaplastic thyroid carcinoma.
    Chen TY; Lorch JH; Wong KS; Barletta JA
    Histopathology; 2020 Aug; 77(2):314-320. PubMed ID: 32428249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal evolution analysis of paired anaplastic and well-differentiated thyroid carcinomas reveals shared common ancestor.
    Dong W; Nicolson NG; Choi J; Barbieri AL; Kunstman JW; Abou Azar S; Knight J; Bilguvar K; Mane SM; Lifton RP; Korah R; Carling T
    Genes Chromosomes Cancer; 2018 Dec; 57(12):645-652. PubMed ID: 30136351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential targetable genes in papillary, follicular, and anaplastic thyroid carcinoma using bioinformatics analysis.
    Agarwal S; Gupta S; Raj R
    Endocrine; 2024 Oct; 86(1):255-267. PubMed ID: 38676768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-Regulation of APTR and it's Diagnostic Value in Papillary and Anaplastic Thyroid Cancer.
    Zhang K; Li C; Liu J; Li Z; Ma C
    Pathol Oncol Res; 2020 Jan; 26(1):559-565. PubMed ID: 30539519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer.
    Han PZ; Ye WD; Yu PC; Tan LC; Shi X; Chen XF; He C; Hu JQ; Wei WJ; Lu ZW; Qu N; Wang Y; Ji QH; Ji DM; Wang YL
    JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38478516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis.
    Song YS; Jung CK; Jung KC; Park YJ; Won JK
    J Korean Med Sci; 2017 Oct; 32(10):1721-1726. PubMed ID: 28875621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differences of regulatory networks between papillary and anaplastic thyroid carcinoma: an integrative transcriptomics study.
    Pan Z; Li L; Qian Y; Ge X; Hu X; Zhang Y; Ge M; Huang P
    Cancer Biol Ther; 2020 Sep; 21(9):853-862. PubMed ID: 32887540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel somatic alterations underlie Chinese papillary thyroid carcinoma.
    Yang C; Xu W; Gong J; Liu Z; Cui D
    Cancer Biomark; 2020; 27(4):445-460. PubMed ID: 32065787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis.
    Lan X; Bao H; Ge X; Cao J; Fan X; Zhang Q; Liu K; Zhang X; Tan Z; Zheng C; Wang A; Chen C; Zhu X; Wang J; Xu J; Zhu X; Wu X; Wang X; Shao Y; Ge M
    Cancer Sci; 2020 Jun; 111(6):2163-2173. PubMed ID: 32187423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
    Nikitski AV; Rominski SL; Condello V; Kaya C; Wankhede M; Panebianco F; Yang H; Altschuler DL; Nikiforov YE
    Thyroid; 2019 Oct; 29(10):1425-1437. PubMed ID: 31298630
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.
    Fourati A; El Amine O; Ben Ayoub W; Cherni I; Goucha A; El May MV; Gamoudi A; El May A
    Bull Cancer; 2017 May; 104(5):433-441. PubMed ID: 28185633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
    Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
    J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Squamous Cell Carcinoma of the Thyroid Has a Molecular Genetic Profile Distinct From That of Anaplastic Thyroid Carcinoma: A Whole Exome Sequencing and Gene Expression Profiling Study.
    Ye M; Guo Z; Xu J; Jin Y; He X; Ge M
    Am J Surg Pathol; 2024 Aug; 48(8):1024-1031. PubMed ID: 38775423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma.
    Siraj AK; Pratheeshkumar P; Parvathareddy SK; Bu R; Masoodi T; Iqbal K; Al-Rasheed M; Al-Dayel F; Al-Sobhi SS; Alzahrani AS; Al-Dawish M; Al-Kuraya KS
    Eur J Cancer; 2019 Aug; 117():133-144. PubMed ID: 31280122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch.
    Hébrant A; Dom G; Dewaele M; Andry G; Trésallet C; Leteurtre E; Dumont JE; Maenhaut C
    PLoS One; 2012; 7(10):e37807. PubMed ID: 23115614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.